Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4866086
Max Phase: Preclinical
Molecular Formula: C42H71N17O9
Molecular Weight: 958.14
Molecule Type: Unknown
Associated Items:
ID: ALA4866086
Max Phase: Preclinical
Molecular Formula: C42H71N17O9
Molecular Weight: 958.14
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H]1CCCNC(=N)NC(=O)NCCCCNC(=O)CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
Standard InChI: InChI=1S/C42H71N17O9/c1-24(2)22-31(38(67)56-28(9-6-20-51-40(46)47)36(65)57-30(34(43)63)23-25-11-13-26(60)14-12-25)58-37(66)29-10-7-21-52-41(48)59-42(68)53-18-4-3-17-49-32(61)15-16-33(62)54-27(35(64)55-29)8-5-19-50-39(44)45/h11-14,24,27-31,60H,3-10,15-23H2,1-2H3,(H2,43,63)(H,49,61)(H,54,62)(H,55,64)(H,56,67)(H,57,65)(H,58,66)(H4,44,45,50)(H4,46,47,51)(H4,48,52,53,59,68)/t27-,28-,29-,30-,31-/m0/s1
Standard InChI Key: JBCDYUYFYHWGEC-QKUYTOGTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 958.14 | Molecular Weight (Monoisotopic): 957.5621 | AlogP: -3.29 | #Rotatable Bonds: 19 |
Polar Surface Area: 438.73 | Molecular Species: BASE | HBA: 12 | HBD: 18 |
#RO5 Violations: 3 | HBA (Lipinski): 26 | HBD (Lipinski): 21 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.75 | CX Basic pKa: 11.96 | CX LogP: -5.59 | CX LogD: -10.78 |
Aromatic Rings: 1 | Heavy Atoms: 68 | QED Weighted: 0.04 | Np Likeness Score: 0.29 |
1. Konieczny A, Conrad M, Ertl FJ, Gleixner J, Gattor AO, Grätz L, Schmidt MF, Neu E, Horn AHC, Wifling D, Gmeiner P, Clark T, Sticht H, Keller M.. (2021) N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding Constants., 64 (22.0): [PMID:34748345] [10.1021/acs.jmedchem.1c01574] |
Source(1):